Quanterix Corp — Financial Data
Annual figures from SEC EDGAR XBRL filings (10-K)
These figures are extracted directly from XBRL-tagged financial statements that Quanterix Corp filed with the SEC as part of its annual 10-K reports. XBRL (eXtensible Business Reporting Language) is a structured data format the SEC requires for machine-readable financial disclosures. Values shown are as reported — negative figures indicate a loss and are shown in red.
Revenue
Total revenue from all business activities — the top line of the income statement. Represents all money earned before any expenses are deducted.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2018 | Dec 31, 2018 | $10.88M | Mar 18, 2019 |
| FY2018 | Sep 30, 2018 | $10.59M | Mar 18, 2019 |
| FY2018 | Jun 30, 2018 | $8.64M | Mar 18, 2019 |
| FY2018 | Mar 31, 2018 | $7.52M | Mar 18, 2019 |
| FY2018 | Dec 31, 2017 | $6.59M | Mar 18, 2019 |
| FY2018 | Sep 30, 2017 | $5.73M | Mar 18, 2019 |
| FY2018 | Jun 30, 2017 | $5.21M | Mar 18, 2019 |
| FY2018 | Mar 31, 2017 | $5.34M | Mar 18, 2019 |
| FY2018 | Dec 31, 2016 | $17.59M | Mar 18, 2019 |
Revenue
Revenue recognized from contracts with customers under ASC 606, excluding taxes collected on behalf of government authorities. This is the primary revenue concept for many companies.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $138.90M | Mar 2, 2026 |
| FY2025 | Dec 31, 2024 | $137.42M | Mar 2, 2026 |
| FY2023 | Dec 31, 2023 | $31.55M | Dec 26, 2024 |
| FY2023 | Sep 30, 2023 | $31.56M | Dec 26, 2024 |
| FY2023 | Jun 30, 2023 | $30.80M | Dec 26, 2024 |
| FY2023 | Mar 31, 2023 | $28.46M | Dec 26, 2024 |
| FY2023 | Dec 31, 2022 | $25.82M | Dec 26, 2024 |
| FY2023 | Sep 30, 2022 | $26.65M | Dec 26, 2024 |
| FY2023 | Jun 30, 2022 | $23.50M | Dec 26, 2024 |
| FY2023 | Mar 31, 2022 | $29.55M | Dec 26, 2024 |
Gross Profit
Revenue minus the cost of goods sold (COGS). Gross profit shows how much revenue remains to cover operating expenses, R&D, and administrative costs before calculating operating income.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $64.96M | Mar 2, 2026 |
| FY2025 | Dec 31, 2024 | $83.10M | Mar 2, 2026 |
| FY2023 | Dec 31, 2023 | $19.41M | Dec 26, 2024 |
| FY2023 | Sep 30, 2023 | $19.41M | Dec 26, 2024 |
| FY2023 | Jun 30, 2023 | $19.42M | Dec 26, 2024 |
| FY2023 | Mar 31, 2023 | $15.99M | Dec 26, 2024 |
| FY2023 | Dec 31, 2022 | $12.64M | Dec 26, 2024 |
| FY2023 | Sep 30, 2022 | $10.31M | Dec 26, 2024 |
| FY2023 | Jun 30, 2022 | $8.32M | Dec 26, 2024 |
| FY2023 | Mar 31, 2022 | $14.10M | Dec 26, 2024 |
Net Income
The bottom-line profit — what remains after all operating expenses, interest, taxes, and other costs are deducted. A negative value means the company reported a net loss for the year.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | ($107.15M) | Mar 2, 2026 |
| FY2025 | Dec 31, 2024 | ($38.53M) | Mar 2, 2026 |
| FY2023 | Dec 31, 2023 | ($8.81M) | Dec 26, 2024 |
| FY2023 | Sep 30, 2023 | ($6.72M) | Dec 26, 2024 |
| FY2023 | Jun 30, 2023 | ($5.55M) | Dec 26, 2024 |
| FY2023 | Mar 31, 2023 | ($7.27M) | Dec 26, 2024 |
| FY2023 | Dec 31, 2022 | ($18.20M) | Dec 26, 2024 |
| FY2023 | Sep 30, 2022 | ($36.55M) | Dec 26, 2024 |
| FY2023 | Jun 30, 2022 | ($26.91M) | Dec 26, 2024 |
| FY2023 | Mar 31, 2022 | ($17.92M) | Dec 26, 2024 |
Operating Income
Profit from core business operations before interest expense and income taxes (also known as EBIT). Excludes non-operating items, making it a cleaner measure of operational efficiency than net income.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | ($125.54M) | Mar 2, 2026 |
| FY2025 | Dec 31, 2024 | ($52.62M) | Mar 2, 2026 |
| FY2023 | Dec 31, 2023 | ($13.62M) | Dec 26, 2024 |
| FY2023 | Sep 30, 2023 | ($12.81M) | Dec 26, 2024 |
| FY2023 | Jun 30, 2023 | ($8.99M) | Dec 26, 2024 |
| FY2023 | Mar 31, 2023 | ($10.58M) | Dec 26, 2024 |
| FY2023 | Dec 31, 2022 | ($21.39M) | Dec 26, 2024 |
| FY2023 | Sep 30, 2022 | ($37.96M) | Dec 26, 2024 |
| FY2023 | Jun 30, 2022 | ($26.96M) | Dec 26, 2024 |
| FY2023 | Mar 31, 2022 | ($17.95M) | Dec 26, 2024 |
R&D Expense
Spending on research and development activities — developing new products, improving existing ones, or conducting basic research. High R&D relative to revenue is common in technology and pharmaceutical companies.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $35.92M | Mar 2, 2026 |
| FY2025 | Dec 31, 2024 | $31.08M | Mar 2, 2026 |
| FY2023 | Dec 31, 2023 | $7.21M | Dec 26, 2024 |
| FY2023 | Sep 30, 2023 | $7.74M | Dec 26, 2024 |
| FY2023 | Jun 30, 2023 | $6.13M | Dec 26, 2024 |
| FY2023 | Mar 31, 2023 | $4.99M | Dec 26, 2024 |
| FY2023 | Dec 31, 2022 | $5.84M | Dec 26, 2024 |
| FY2023 | Sep 30, 2022 | $6.83M | Dec 26, 2024 |
| FY2023 | Jun 30, 2022 | $7.26M | Dec 26, 2024 |
| FY2023 | Mar 31, 2022 | $6.88M | Dec 26, 2024 |
SG&A Expense
Selling, general, and administrative expenses — the overhead costs of running the business, including salaries, marketing, legal fees, and corporate office costs. Excludes COGS and R&D.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $138.01M | Mar 2, 2026 |
| FY2025 | Dec 31, 2024 | $101.62M | Mar 2, 2026 |
| FY2023 | Dec 31, 2023 | $23.44M | Dec 26, 2024 |
| FY2023 | Sep 30, 2023 | $23.55M | Dec 26, 2024 |
| FY2023 | Jun 30, 2023 | $21.31M | Dec 26, 2024 |
| FY2023 | Mar 31, 2023 | $20.82M | Dec 26, 2024 |
| FY2023 | Dec 31, 2022 | $18.39M | Dec 26, 2024 |
| FY2023 | Sep 30, 2022 | $20.48M | Dec 26, 2024 |
| FY2023 | Jun 30, 2022 | $27.82M | Dec 26, 2024 |
| FY2023 | Mar 31, 2022 | $25.17M | Dec 26, 2024 |
Operating Cash Flow
Cash generated from core business operations — a more reliable measure of financial health than net income because it strips out non-cash items like depreciation and one-time charges.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | ($77.24M) | Mar 2, 2026 |
| FY2025 | Dec 31, 2024 | ($35.16M) | Mar 2, 2026 |
| FY2025 | Dec 31, 2023 | ($18.85M) | Mar 2, 2026 |
| FY2023 | Sep 30, 2023 | ($12.66M) | Dec 26, 2024 |
| FY2023 | Jun 30, 2023 | ($8.79M) | Dec 26, 2024 |
| FY2023 | Mar 31, 2023 | ($9.82M) | Dec 26, 2024 |
| FY2024 | Dec 31, 2022 | ($48.61M) | Mar 17, 2025 |
| FY2023 | Sep 30, 2022 | ($44.52M) | Dec 26, 2024 |
| FY2023 | Jun 30, 2022 | ($29.72M) | Dec 26, 2024 |
| FY2023 | Mar 31, 2022 | ($21.76M) | Dec 26, 2024 |
Capital Expenditures (Capex)
Cash spent on acquiring or upgrading physical assets — property, equipment, and infrastructure. High capex businesses include manufacturing, telecom, and energy companies.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $2.61M | Mar 2, 2026 |
| FY2025 | Dec 31, 2024 | $3.37M | Mar 2, 2026 |
| FY2025 | Dec 31, 2023 | $3.84M | Mar 2, 2026 |
| FY2023 | Sep 30, 2023 | $1.88M | Dec 26, 2024 |
| FY2023 | Jun 30, 2023 | $947.0K | Dec 26, 2024 |
| FY2023 | Mar 31, 2023 | $136.0K | Dec 26, 2024 |
| FY2024 | Dec 31, 2022 | $11.61M | Mar 17, 2025 |
| FY2023 | Sep 30, 2022 | $10.02M | Dec 26, 2024 |
| FY2023 | Jun 30, 2022 | $6.34M | Dec 26, 2024 |
| FY2023 | Mar 31, 2022 | $1.34M | Dec 26, 2024 |
Total Assets
The total value of everything the company owns or controls — cash, investments, receivables, property, equipment, and intangibles. Reported as of fiscal year end.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $418.77M | Mar 2, 2026 |
| FY2025 | Dec 31, 2024 | $406.53M | Mar 2, 2026 |
| FY2024 | Dec 31, 2023 | $428.57M | Mar 17, 2025 |
| FY2023 | Sep 30, 2023 | $429.22M | Dec 26, 2024 |
| FY2023 | Jun 30, 2023 | $428.27M | Dec 26, 2024 |
| FY2023 | Mar 31, 2023 | $425.72M | Dec 26, 2024 |
| FY2023 | Dec 31, 2022 | $433.58M | Dec 26, 2024 |
| FY2023 | Sep 30, 2022 | $445.57M | Dec 26, 2024 |
| FY2023 | Jun 30, 2022 | $488.68M | Dec 26, 2024 |
| FY2023 | Mar 31, 2022 | $506.69M | Dec 26, 2024 |
Total Liabilities
All financial obligations owed to outside parties — including debt, accounts payable, accrued expenses, and deferred revenue. Subtracting liabilities from total assets gives stockholders' equity.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $123.04M | Mar 2, 2026 |
| FY2025 | Dec 31, 2024 | $76.50M | Mar 2, 2026 |
| FY2024 | Dec 31, 2023 | $78.61M | Mar 17, 2025 |
| FY2023 | Sep 30, 2023 | $76.43M | Dec 26, 2024 |
| FY2023 | Jun 30, 2023 | $74.52M | Dec 26, 2024 |
| FY2023 | Mar 31, 2023 | $70.53M | Dec 26, 2024 |
| FY2023 | Dec 31, 2022 | $75.65M | Dec 26, 2024 |
| FY2023 | Sep 30, 2022 | $74.28M | Dec 26, 2024 |
| FY2023 | Jun 30, 2022 | $83.21M | Dec 26, 2024 |
| FY2023 | Mar 31, 2022 | $78.23M | Dec 26, 2024 |
Stockholders Equity
The net worth attributable to shareholders: total assets minus total liabilities. Also called book value. Can be negative if liabilities exceed assets, which is common in capital-intensive industries.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $295.73M | Mar 2, 2026 |
| FY2025 | Dec 31, 2024 | $330.04M | Mar 2, 2026 |
| FY2025 | Dec 31, 2023 | $349.96M | Mar 2, 2026 |
| FY2023 | Sep 30, 2023 | $352.79M | Dec 26, 2024 |
| FY2023 | Jun 30, 2023 | $353.75M | Dec 26, 2024 |
| FY2023 | Mar 31, 2023 | $355.19M | Dec 26, 2024 |
| FY2025 | Dec 31, 2022 | $357.93M | Mar 2, 2026 |
| FY2023 | Sep 30, 2022 | $371.29M | Dec 26, 2024 |
| FY2023 | Jun 30, 2022 | $405.47M | Dec 26, 2024 |
| FY2023 | Mar 31, 2022 | $428.46M | Dec 26, 2024 |
Goodwill
An intangible asset representing the premium paid above fair value when acquiring another company. A large goodwill balance signals a history of acquisitions at premium prices.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $26.38M | Mar 2, 2026 |
| FY2025 | Dec 31, 2024 | $0 | Mar 2, 2026 |
| FY2023 | Dec 31, 2023 | $0 | Dec 26, 2024 |
| FY2023 | Dec 31, 2022 | $0 | Dec 26, 2024 |
| FY2023 | Jun 30, 2022 | $8.68M | Dec 26, 2024 |
| FY2023 | Mar 31, 2022 | $9.32M | Dec 26, 2024 |
| FY2022 | Dec 31, 2021 | $9.63M | Mar 6, 2023 |
| FY2021 | Dec 31, 2020 | $10.46M | Mar 1, 2022 |
| FY2020 | Dec 31, 2019 | $9.35M | Mar 5, 2021 |
| FY2019 | Dec 31, 2018 | $1.31M | Mar 13, 2020 |
Retained Earnings
Cumulative net income kept by the company rather than distributed as dividends. A growing retained earnings balance indicates consistent profitability; a deficit indicates cumulative losses.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | ($577.23M) | Mar 2, 2026 |
| FY2025 | Dec 31, 2024 | ($470.08M) | Mar 2, 2026 |
| FY2024 | Dec 31, 2023 | ($431.55M) | Mar 17, 2025 |
| FY2023 | Sep 30, 2023 | ($422.74M) | Dec 26, 2024 |
| FY2023 | Jun 30, 2023 | ($416.02M) | Dec 26, 2024 |
| FY2023 | Mar 31, 2023 | ($410.47M) | Dec 26, 2024 |
| FY2023 | Dec 31, 2022 | ($403.20M) | Dec 26, 2024 |
| FY2023 | Sep 30, 2022 | ($385.00M) | Dec 26, 2024 |
| FY2023 | Jun 30, 2022 | ($348.45M) | Dec 26, 2024 |
| FY2023 | Mar 31, 2022 | ($321.54M) | Dec 26, 2024 |
Cash & Equivalents
Highly liquid assets the company holds — cash on hand, bank balances, and short-term investments with maturities of three months or less. A key indicator of short-term financial health.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $29.84M | Mar 2, 2026 |
| FY2025 | Dec 31, 2024 | $56.71M | Mar 2, 2026 |
| FY2024 | Dec 31, 2023 | $174.42M | Mar 17, 2025 |
| FY2023 | Sep 30, 2023 | $201.26M | Dec 26, 2024 |
| FY2023 | Jun 30, 2023 | $329.53M | Dec 26, 2024 |
| FY2023 | Mar 31, 2023 | $329.35M | Dec 26, 2024 |
| FY2023 | Dec 31, 2022 | $338.74M | Dec 26, 2024 |
| FY2023 | Sep 30, 2022 | $343.74M | Dec 26, 2024 |
| FY2023 | Jun 30, 2022 | $361.55M | Dec 26, 2024 |
| FY2023 | Mar 31, 2022 | $374.54M | Dec 26, 2024 |
Long-Term Debt
Debt obligations due more than one year from the balance sheet date — bonds, term loans, and notes payable. High long-term debt relative to equity can signal elevated financial leverage.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2020 | Dec 31, 2020 | $7.69M | Mar 5, 2021 |
| FY2019 | Dec 31, 2019 | $7.69M | Mar 13, 2020 |
| FY2018 | Dec 31, 2018 | $7.76M | Mar 18, 2019 |
EPS (Basic)
Net income divided by the weighted average shares outstanding. Basic EPS does not account for dilutive securities like options or convertible bonds — use diluted EPS for a more conservative view.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | (2) | Mar 2, 2026 |
| FY2025 | Dec 31, 2024 | (1) | Mar 2, 2026 |
| FY2023 | Dec 31, 2023 | 0 | Dec 26, 2024 |
| FY2023 | Sep 30, 2023 | 0 | Dec 26, 2024 |
| FY2023 | Jun 30, 2023 | 0 | Dec 26, 2024 |
| FY2023 | Mar 31, 2023 | 0 | Dec 26, 2024 |
| FY2023 | Dec 31, 2022 | 0 | Dec 26, 2024 |
| FY2023 | Sep 30, 2022 | 0 | Dec 26, 2024 |
| FY2023 | Jun 30, 2022 | 0 | Dec 26, 2024 |
| FY2023 | Mar 31, 2022 | 0 | Dec 26, 2024 |
EPS (Diluted)
Net income divided by the fully diluted share count — including all potential shares from options, warrants, and convertible instruments. The more conservative and widely cited EPS figure.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | (2) | Mar 2, 2026 |
| FY2025 | Dec 31, 2024 | (1) | Mar 2, 2026 |
| FY2023 | Dec 31, 2023 | 0 | Dec 26, 2024 |
| FY2023 | Sep 30, 2023 | 0 | Dec 26, 2024 |
| FY2023 | Jun 30, 2023 | 0 | Dec 26, 2024 |
| FY2023 | Mar 31, 2023 | 0 | Dec 26, 2024 |
| FY2023 | Dec 31, 2022 | 0 | Dec 26, 2024 |
| FY2023 | Sep 30, 2022 | 0 | Dec 26, 2024 |
| FY2023 | Jun 30, 2022 | 0 | Dec 26, 2024 |
| FY2023 | Mar 31, 2022 | 0 | Dec 26, 2024 |
Shares Outstanding
Total common shares issued and held by all shareholders, excluding treasury shares. Combined with market price gives market capitalization.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | 46.74M | Mar 2, 2026 |
| FY2025 | Dec 31, 2024 | 38.57M | Mar 2, 2026 |
| FY2024 | Dec 31, 2023 | 38.01M | Mar 17, 2025 |
| FY2023 | Sep 30, 2023 | 37.84M | Dec 26, 2024 |
| FY2023 | Jun 30, 2023 | 37.57M | Dec 26, 2024 |
| FY2023 | Mar 31, 2023 | 37.42M | Dec 26, 2024 |
| FY2023 | Dec 31, 2022 | 37.28M | Dec 26, 2024 |
| FY2023 | Sep 30, 2022 | 37.09M | Dec 26, 2024 |
| FY2023 | Jun 30, 2022 | 36.98M | Dec 26, 2024 |
| FY2023 | Mar 31, 2022 | 36.90M | Dec 26, 2024 |